1. Phase III ASAP trial

https://ash.confex.com/ash/2022/webprogram/Paper159962.html

2. Phase III Dauno-Double Trial

https://ash.confex.com/ash/2022/webprogram/Paper157126.html

3. Reduced venetoclax exposure:

https://ash.confex.com/ash/2022/webprogram/Paper165464.html

4. Menin Inhibitors in AML

https://ash.confex.com/ash/2022/webprogram/Paper164849.html

https://ash.confex.com/ash/2022/webprogram/Paper167412.html

5. Imetelstat in MDS: IMerge Phase 2

https://ash.confex.com/ash/2022/webprogram/Paper169050.html

6. MOMENTUM: Momelotinib

https://ash.confex.com/ash/2022/webprogram/Paper162783.html

How I manage anemia related to myelofibrosis and its treatment regimens

https://link.springer.com/article/10.1007/s00277-023-05126-4

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk